As we develop our own biological models, R&D is the heart of our company. We strongly believe in cooperation and we are part of several programmes:
To ensure personalised treatment for familial hypercholesterolemia
Face to the high failure of drug candidate in clinical trial, in particular involving the brain, we goal to develop more relevant and more predictive in vitro models for preclinical assessment, in the aim to early select molecules of interest, in term of efficacy and safety.
To design and industrialize new pharmacological in vitro assays for the screening of compounds/biopharmaceuticals in 3D
To deliver a technology platform consisting of bovine cell lines that are easily transformed into fat and muscle cells, a highly efficient cell expansion process, and a tailor-made bioreactor-scaffold combination to generate pieces of meat.
To develop a universal “plug-and-play” liver-on-chip platform mimicking the major events occurring in the liver sinusoid in order to predict the hepatoxicity of drugs.